2
J.B. Nanubolu et al. / Journal of Molecular Structure xxx (2013) xxx–xxx
literature, for which the high Z0 form is genuinely more stable than
1. Introduction
low Z0 form [5b,13a–d] or the compounds crystallize exclusively
with Z0 > 1 structures [4c,13e,f].
The Z0 parameter is conventionally used in the crystallography
to denote the number of molecules in the asymmetric unit [1].
Strictly it is defined as the number of formula units in the unit cell
(Z) divided by the number of independent general positions of the
crystal space group [2]. In general, 90% of the molecules crystallize
with a single molecule or less (Z0 6 1), while a small but significant
fraction of the compounds (8.3%) contain more than one molecule
in the asymmetric unit (Z0 > 1) [3]. The incidence of structures with
Z0 > 1 has interestingly remained almost invariant over the two
decades (8.3% in 1990, 8.8% in 2006, 11.5% in 2009) [3,4]. With
the rising interest in organic crystal structure prediction and appli-
cations of organic materials in the pharmaceutical industry, it is
necessary to understand this phenomenon to ascertain if there is
any direct relationship between its occurrence and attributes such
as the molecular structure, chemical functionality, crystal system
and etc. [5]. Few authors have made an attempt in the past and
concluded that Z0 > 1 situation is often observed in low symmetry
triclinic and monoclinic space groups P1, P21/c and Pc [3,6a]. The
chiral molecules without internal symmetry have noticeably high-
er percentage of Z0 > 1 structures [4b]. Further, the precedence of
Z0 > 1 is more for certain class of compounds, such as nucleosides
and nucleotides (20.8%) and steroids (18.8%). This indicates a gen-
eral packing problem of the awkwardly shaped molecules which
often cannot crystallize out in simple packing modes with Z0 = 1
[4b]. Gavezzotti and Fillippini [6b] noted Z0 > 1 cases are more pro-
nounced in the case of hydrogen bonded crystals. Brock and Dun-
can [6a] provided logical reasons to the anomalous space group
frequencies for mono alcohols (ꢃ51%). Nangia [7] suggested that
there may be several low-lying, interconverting conformers in
solution and more than one may crystallize simultaneously be-
cause of the kinetic factors. Craven [8a], Desiraju [8b], Zorky [8c],
Britton [8d], Kuleshova [8e], Gavezzotti [8f], Dunitz and Bernstein
[8g] have emphasized the presence of pseudosymmetry in Z0 > 1
structures.
In an attempt to understand the dependence of polymorph sta-
bility on the number of molecules in the asymmetric unit, we have
analyzed a dimorphic system of 7-benzoyl-1,3-dihydroindol-2-one
in the present article. Form I crystallizes in the triclinic space
0
ꢀ
group, P1 with Z = 2 and form II crystallizes in the monoclinic
space group, P21/c, with Z0 = 1. Polymorphs are characterized by
single crystal X-ray diffraction (SC-XRD), powder X-ray diffraction
(PXRD) and Infrared spectroscopy (IR). The stability relationship is
established by Differential Scanning Calorimetry (DSC) and phase
transformation studies by grinding, slurry and thermal methods.
The conformer and lattice energy calculations are performed for
better understanding of the stability of crystal structures. Finally
a statistical analysis on polymorphic pairs with variable Z0 is car-
ried out to indicate the trends.
2. Experimental section
2.1. Materials and methods
Prior to setting up various crystallizations, napafenac (In-house
sources from IICT) was recrystallized and confirmed to be pure by
1H NMR. Further, the materials were identified as single phase
crystalline form by PXRD.
2.2. Synthesis and crystal growth
100 mg of napafenac was dissolved in 20 mL ethanol solution
under hot conditions. A clear yellow solution was obtained to
which four drops of conc. HCl were added. The yellowish ethanolic
solution turned to colorless within 2–3 min. Napafenac was cy-
clized to 7-benzoyl-1,3-dihydroindol-2-one. Crystals of the cy-
clized product (form I and II) were concomitantly observed upon
slow evaporation of the ethanol solvent.
Steed [2a] in his seminal work has critically reviewed the rea-
sons for Z0 > 1 structures. Their structural origins are linked to
the early events of crystallization such as molecular aggregation
and crystal nucleation. Accordingly, these have been referred as
‘‘fossil relic’’ of the fastest growing crystal nucleus or ‘‘early snap-
shot or kinetic form’’ [2a]. Desiraju [4a] suggested that the secrets
about the high Z0 structures may be best revealed in a polymorphic
system with variable Z0, as the high Z0 form can be directly com-
pared with its low Z0 (typically 1) polymorph. The term ‘‘poly-
morph’’ indicates a solid crystalline phase of a given compound
resulting from the possibility of at least two crystalline arrange-
ments of molecules of that compound, a phenomenon which has
high relevance to the pharmaceutical industry [9]. The polymorph
with higher Z0 structure is suggested to be ‘‘crystal on the way’’
meaning that it represents to a less stable high energy polymorph
(or in other words a kinetic form) in the crystallization pathway to-
wards the final thermodynamic crystal form with the lower Z0 [10].
The kinetic nature of high Z0 structures is seemed to be evident
from the higher proportion of Z0 > 1 structures grown from melt
or sublimation (fast crystallization conditions) as noted by Nangia
[11]. Clegg [12], on similar lines showed that the early stages of
crystal nuclei (poor quality crystals which are formed too rapidly
or incompletely crystallized) determined by synchrotron radiation
have greater proportion of Z0 > 1 (21%) followed by conventional X-
ray determined structures (12%). The slowly formed large crystals
grown for neutron diffraction have the lowest incidence of multi-
ple molecules (5%). While the above studies clearly suggest the
high Z0 structures to be metastable fossil relics or forms of arrested
crystallization, there are however few counter examples in the
2.3. Spectroscopic (NMR, IR and Mass) data
1H NMR of 7-benzoyl-1,3-dihydroindol-2-one (DMSO-d6):
d3.61(2H, s), 6.92 (1H, d), 7.06(1H, t), 7.31(1H, t), 7.46(1H, d),
7.55(2H, t), 7.70(2H, m), 10.35(1H, s). The m/z: 237; IR (KBr):
3268.1, 3047.6, 2910.7, 1733.4, 1711.8, 1647.0, 1595.7, 1475.5,
1447.3, 1383.0, 1333.1, 1304.5, 1252.9, 1206.2, 1171.1, 1070.9,
1036.2, 1013.6 cmꢂ1 1H NMR of napafenac (DMSO-d6): d3.42
.
(2H, s), 6.53(1H, t), 7.07(3H, d), 7.20(1H, dd), 7.25(1H, dd),
7.55(6H, m). IR: 3444.8, 3323.3, 3193.1, 1676.7, 1616.4, 1555.1,
1437.5, 1437.5, 1400.9, 1333.9, 1282.7, 1243.9, 1194.3,
1171.1 cmꢂ1
. The NMR spectrum is recorded on BRUKER
AVANCE-300 NMR spectrometer, FT-IR spectra on Thermo Nicolet
spectrometer, Model Nexus 670, USA.
2.4. Single crystal X-ray diffraction (SC-XRD)
Crystal data were collected at RT using a Bruker Smart Apex
CCD diffractometer with graphite monochromated Mo K
a radia-
tion (k = 0.71073 Å) with -scan method. Preliminary lattice
x
parameters and orientation matrices were obtained from four sets
of frames. Integration and scaling of intensity data was accom-
plished using SAINT program [14a]. The structures were solved
by Direct Methods using SHELXS97 and refinement was carried
out by full-matrix least-squares technique using SHELXL97 [14b].
Anisotropic displacement parameters were included for all non-
hydrogen atoms. All H atoms were positioned geometrically and